Pipeline Program 3

About Discovery Biotech

Discovery Biotech is a private, clinical-stage biotechnology company founded in 2018, headquartered in San Diego, USA. The company is developing a pipeline of small molecule drug candidates specifically designed to address the critical challenge of Cancer Treatment Resistance Therapy (CTRT). With an initial portfolio of four products resulting from 15 years of foundational research, the company operates as a pre-revenue entity advancing therapies through preclinical and clinical development. Its business model is centered on therapeutic development, aiming to deliver novel drug inventions ready for clinical trials.

Therapeutic Areas

Other Cancer Treatment Resistance Drugs